3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Leukemia, Myeloid, Acute
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Neuroblastoma
2
Melanoma
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
Leukemia
2
Endometrial Neoplasms
2
Congenital Abnormalities
2
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Squamous Intraepithelial Lesions
1
Squamous Cell Carcinoma of Head and Neck
1
Sarcoma, Synovial
1
Sarcoma, Alveolar Soft Part
1
Sarcoma
1
Pleuropulmonary blastoma
1
Papillomavirus Infections
1
Pain
1
Neurofibrosarcoma
1
Neoplasms
1
Myeloproliferative Syndrome, Transient
1
Meningioma
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Lung Neoplasms
1
Liposarcoma
1
Leukemia, Eosinophilic, Acute
1
Interventions
Polymerase Chain Reaction
5
Watchful Waiting
2
Taxes
2
Paclitaxel
2
Light Coagulation
2
Imiquimod
2
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
2
Gene Expression Profiling
2
Fluorouracil
2
Flow Cytometry
2
Etoposide
2
Cyclophosphamide
2
Cisplatin
2
Carboplatin
2
Biopsy
2
nirogacestat
1
fludarabine
1
emvododstat
1
carmustine, poliferprosan 20 drug combination
1
axicabtagene ciloleucel
1
Vorinostat
1
Vincristine
1
Vinblastine
1
Sodium Chloride
1
Smoking Devices
1
Restraint, Physical
1
Remote Patient Monitoring
1
Radiotherapy
1
Radiation
1
Procarbazine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
HIV Infections
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts